China and Russia veto risk aids DPRK missile response
China and Russia submitted a Security Council draft resolution that strongly deplores North Korea's July 4 missile tests while endorsing only voluntary restraints on Pyongyang's missile and nuclear programs. The move aims to block mandatory sanctions backed by the United States and its allies, forcing concessions to gain Beijing's and Moscow's support or face a veto. China’s ambassador Wang Guangya signaled readiness to veto a U.S. proposal for sanctions.
MENTIONED IN THIS ARTICLE
North Korea
Pyong
United States
Japan
Beijing
Moscow
Wang Guangya
FDA approves single pill HIV treatment Atripla
The FDA approves Atripla the first one pill a day HIV drug combining Viread Emtriva and Sustiva from Gilead and Bristol-Myers Squibb. The price for a 30 day supply is 1150.88 and availability is within seven business days. The pill aims to improve adherence and reduce resistance and costs for patients.
MENTIONED IN THIS ARTICLE
Los Angeles Times
Andrew von Eschenbach
Food and Drug Administration
Gilead Sciences Inc
Foster City
Calif
Sustiva
Bristol-Meyers Squibb Co
Atripla
Emtriva
Joseph Cadden
University of Southern California
Keck School of Medicine
Also Mentioned on This Page
China
Russia
United Nations
U.N. Security Council
Yang’s
U.N
FDA
2Nd St
LOWES
Ender
Top Choi
Whitewood
James Hardie
Hardibacker
Lowe's
Korky Universal
Werner
Pomanty
LOWE
Lowes.com
Plumbersland
Cael
Hes Oe
Muck
Mens Co
AAI
Brooklyn
Putnam County
Texas